Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis. - Wikidata - awgldk - TriplyDB

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.

http://www.wikidata.org/entity/Q37689041

about

Research progress of neuroblastoma related gene variations.Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiopeínas®) in SK-N-SH neuroblastoma cells after short exposure times.Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo.

P2860

Q33566987-6639EC65-0417-4BF3-A84E-C9DEFB18B8E5 Q37702115-DA0F5D03-97EB-449E-A812-44EE6D49A390 Q38725601-A8069AA8-3579-4654-9347-D28CBBEE7462 Q47123875-BD8A633A-517E-442B-93C2-B68A892FCC68

P2860

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.

http://www.wikidata.org/entity/Q37689041

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@en

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@nl

type

label

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@en

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@nl

prefLabel

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@en

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@nl

P1433

Q37689041-02F44CA0-A86E-4401-A764-88A65675FCB3

P1476

Q37689041-5004D580-8340-4B0C-8E91-7C06302F5DA3

P2093

Q37689041-00669CFB-59CD-4FD8-A1BE-6235499118C1

Q37689041-0757D36B-106D-4264-A35D-44E19D875C3F

Q37689041-13087213-14A2-44A1-9F00-D14DD2966F09

Q37689041-1F9322DA-2AEB-452E-A1EB-A60FF072FBEE

Q37689041-2A376B59-E3C8-47DC-9F1A-CBFCD4AF4F61

Q37689041-4D8C142C-F2BF-4FC9-BAFB-21D064FFB968

Q37689041-500F9563-B71B-49A2-9175-2D5282171D73

Q37689041-86C8404C-4B97-4A11-986C-1CC43127B23B

Q37689041-8F640DF5-5FF2-4810-A885-42E3CA72A59F

Q37689041-99AB132C-6FBC-4139-B0D4-687DDF0F1E9B

P2860

Q37689041-03860655-1C3A-408F-A330-F6C870486E02

Q37689041-0EC0DB7C-AC2C-4A0B-95B8-CD69E46B764B

Q37689041-1ECCF258-B3EB-4157-A173-5A180D788ABB

Q37689041-22961A55-1318-41B9-9187-2EE68A03D618

Q37689041-28FA290F-1558-4BC1-B667-AAABC0FE85F8

Q37689041-34409B67-97A9-4AB1-8048-6F55DFAA6EA8

Q37689041-37F62DFC-87F3-43DE-9449-5B9F5F33D57B

Q37689041-3E66FAD7-4453-4C0C-A9C0-B78211F0834C

Q37689041-477B5529-A4F0-41F3-B7B2-9A37296A350F

Q37689041-4F7194F6-2797-4E7A-91D2-8B97A067C190

P304

Q37689041-E3DF3379-02D8-4AE8-98FF-06712904AD67

P31

Q37689041-09DE5C5E-C395-46E3-98F0-B3D20357182F

P356

Q37689041-A2CA33C4-E5F3-469E-82B3-2F9281D1426C

P407

Q37689041-C6E98195-5879-438D-ADDD-6C742B35F247

P433

Q37689041-8A1DCA07-E3F7-4ED1-B318-E9C9BCA82BB9

P478

Q37689041-F8706ED7-D363-48EB-AE78-448767140147

P577

Q37689041-98F1B194-0ADD-4BE3-BCB2-4228C6E65840

P698

Q37689041-A4BDDAB5-5C5C-4E37-A96B-2850BBDB12A7

P921

Q37689041-B6552436-549A-4465-88E5-68FC7CDD03ED

P932

Q37689041-3254DDE1-6FCB-4365-B0F5-7DE3D9634305

P356

ONCOTARGET.12427

P1433

P1476

Second-generation proteasome i ...... doxorubicin-induced apoptosis.

@en

P2093

Jessie Pan

http://www.w3.org/2001/XMLSchema#string

Jianhua Yang

http://www.w3.org/2001/XMLSchema#string

Jiaxiong Lu

http://www.w3.org/2001/XMLSchema#string

Shan Guan

http://www.w3.org/2001/XMLSchema#string

Surong Sun

http://www.w3.org/2001/XMLSchema#string

Wenjing Sun

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Xinfang Mao

http://www.w3.org/2001/XMLSchema#string

Yang Yu

http://www.w3.org/2001/XMLSchema#string

Yanling Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.

The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor

NF-κB in acute pancreatitis: Mechanisms and therapeutic potential.

Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm.

The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.

Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.

In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells

P304

75914-75925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12427

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27713150

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

5342787

http://www.w3.org/2001/XMLSchema#string